期刊文献+

低频超声对Molt-4肿瘤细胞的生物学效应 被引量:7

Bio-effects of Molt-4 cells by low frequency ultrasound
下载PDF
导出
摘要 目的 研究低频超声对Molt 4肿瘤细胞的生物学效应 ,评价低频超声在肿瘤治疗中的应用价值。方法 应用流式细胞术和共聚焦显微镜技术研究低频超声 ( 2 0kHz ,0 .2W /cm2 )持续辐照Molt 4肿瘤细胞 1分钟后的细胞凋亡率和细胞凋亡形态学改变 ,以及细胞凋亡增殖比 (APR)的变化。结果 对照和辐照组细胞凋亡率分别为 ( 2 .5 6± 0 .61) %和 ( 11.0 6± 1.99) % (P <0 .0 1)。细胞凋亡具有特征性形态学改变 ,APR上调。结论 低频超声在体外可诱导Molt 4肿瘤细胞凋亡和抑制肿瘤细胞增殖 。 Objective To observe the bio-effects of Molt-4 cells treated with low frequency ultrasound, and to study the feasibility of cancer treatment by low frequency ultrasound. Methods The changes of percentage and morphology of apoptosis and ratio of apoptosis to proliferation (APR) after ultrasonic exposure (20 kHz, 0.2 W/cm^2, 1 min) were analyzed with FCM and confocal imaging. Results The percentage of apoptosis in control group (n=8) and interventional group (n=8) was (2.56±0.61)% and (11.06±1.99)%, respectively (P<0.01). The apoptic cells had characteristic changes in morphology by confocal. The ratio of apoptosis to proliferation was up-regulated. Conclusion Low frequency ultrasound may offer conference of cancer therapy with its capacity of inducing cancer cells' apoptosis and inhibiting its proliferation in vitro. [
出处 《中国医学影像技术》 CSCD 2004年第11期1670-1672,共3页 Chinese Journal of Medical Imaging Technology
关键词 低频超声 细胞凋亡 肿瘤治疗 Low frequency ultrasound Apoptosis: Cancer therapy
  • 相关文献

参考文献1

二级参考文献18

  • 1Nagata Y, Araki N, Kimura H, et al. Neoadjuvant chemotherapy by transcatheter arterial infusion method for uterine cervical cancer [J]. J Vasc Interv Radiol 2000; 11:313.
  • 2Aoki Y, Sato T, Watanabe M, et al. Neoadjuvant chemotherapy using low-dose consecutive intraarterial infusions of cisplatin combined with 5-fluorouracil forlocally advanced cervical adenocarcinoma [J]. Gynecol Oncol 2001; 81:496.
  • 3Umeki H, Yamaguchi Y, Tsugata M, et al. Neoadjuvant intraarterial chemotherapy with nedaplatin, peplomycin and mitomycin C for advanced cervical cancer [J]. Gan To Kagaku Ryoho 2003; 30:377.
  • 4Moore DH. Neoadjuvant chemotherapy for cervical cancer [J]. Expert Opin Pharmacother 2003; 4:859.
  • 5Aoki Y, Tanaka K. Current approaches of neoadjuvant chemotherapy in cervical cancer [J]. Expert Rev Anticancer Ther 2002; 2:73.
  • 6Minagawa Y, Onohara Y, Takahashi H, et al. Blood flow after intraarterial infusion chemotherapy in a patient with advanced cervical cancer [J]. Gynecol Obstet Invest 2001 ; 52:278.
  • 7Sheridan MT, Cooper RA, West CM. A high ratio of apoptosis to proliferation correlates with improved survival after radiotherapy for cervical adenocarcinoma[J]. Int J Radia Oncol Biol Phys 1999; 44:507.
  • 8Napolitano U, Imperato F, Mossa B, et al. The role of neoadjuvant chemotherapy for squamous cell cervicalcancer (Ib-Ⅲb): a long-term randomized trial [J]. Eur J Gynaecol Oncol 2003; 24:51.
  • 9Benedetti-Panici P, Greggi S, Scambia G, et al.Long-term survival following neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer[J]. Eur J Cancer 1998; 34:341.
  • 10Kamoi S, Ohaki Y, Okada S, et al. Mitotic index and ki-67 nuclear antigen labeling index as predictors of chemotherapy response in uterine cervical carcinoma [J].Gynecol Oncol 2001; 83:555.

同被引文献67

引证文献7

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部